U.S. COMPANY FILING
BOSTON SCIENTIFIC CORP — Form 10-Q filed 2026-08-03
Filing text preview
Boston Scientific reported Q2 2026 net sales of $5.442 billion, up 7.5% YoY, and H1 net sales of $10.646 billion, up 9.5%. The company made strategic investments including $1.5 billion in MiRus with an option to acquire its TAVR business. Operating cash flow was $1.822 billion, with $2 billion share repurchases. Litigation charges of $76 million were recorded.
This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.
Open filing record